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Introduction 
The biological activity of vanadium compounds with organic 
ligands is multidirectional – they are known for exhibiting sev-
eral bioactivities [1-2] and showing potential as pharmaceutical 
drugs [3]. Vanadium can occur at various degrees of oxidation 
from -3 to +5 and the state of vanadium in a compound is highly 
dependent on pH [4], most often as four- and five-valent deriva-
tives, while compounds in the form of trivalent derivatives are 
unstable in the presence of oxygen under physiological condi-
tions. Thus, in most applications and studies on biological activ-
ity vanadium is in form of V(IV) or V(V) salts. It is postulated 
that cation V(IV) readily oxidizes to V(V) and occurs in living 
organisms as an anion [5]. At the beginning simple vanadium 
inorganic salts were used, as vanadyl sulphate or vanadates. 
In 90’s first vanadium(IV) complex with maltolato ligand was 
synthesized and soon application of more bioactive complex-
es with organic ligands has started. It is also worth noting that 
vanadium compounds exhibit large differences between them 
in terms of their structure and, therefore, show a difference in 
permeability through the cell membrane to the body. Vanadium 
derivatives have antidiabetic [6-8], anticancer effects [9-13] and 
lower blood pressure [14]. What is more, it is said that they show 
greater activity in comparison to the commonly used anticancer 
drugs [15]. For many years vanadium compounds have shown 
also their insulin-enhancing and insulin-mimetic effects in 
treatment of diabetes [16-17]. Further research on this group of 
transition metal complexes can lead to progress in improvement 
of innovative metal-based therapeutic drugs.
In this paper we described the results of the research which 
aim was to compare vanadium complexes with diverse struc-
tures and correlate it with their properties, which is important 
from the point of view of their subsequent pharmacological 
application. In reference to these observations, we synthesized 
a group of vanadium complexes at three different oxidation lev-
els (III, IV and V) showing differences in the coordination of the 
metal with the ligand in order to compare their physicochemical 
and spectroscopic properties as potential antidiabetic drugs. The 
complexes were obtained from different vanadium compounds 
such as: [V(acac)3], [VO(acac)2] and VOSO4 and ONO hydrazine 
Schiff base ligands derived from 3,5-dibromo-4-methoxy-sa-
licylaldehyde with phenylacetic hydrazide, 5-chlorosalicylalde-
hyde with the following hydrazides: 4-hydroxybenzhydrazide 
and 2-hydroxybenzhydrazide. For all of the complexes the el-
emental analysis, IR, UV-Vis spectra, magnetic susceptibility 
and cyclic voltammetry, as well as EPR for one of the com-
pounds, are presented. 
Materials and Methods 
[V(acac)3], [VO(acac)2], VOSO4aq, 3,5-dibromo-4-methoxy-sa-
licylaldehyde, 5-chlorosalicylaldehyde, phenylacetic hydrazide, 
4-hydroxybenzhydrazide and 2-hydroxybenzhydrazide, 
1,10-phenanthroline were of analytical grade (Aldrich) and were 
used as supplied. Ethanol (98%) of pharmaceutical grade was 
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from Polmos (Poland) and used as supplied. All other solvents 
were of analytical grade and were used as supplied. BaSO4 was 
of spectroscopic grade (Japan). Microanalysis of carbon, hy-
drogen and nitrogen were performed using Elementar Vario 
MICRO Cube elemental analyzer. IR spectra were recorded on 
a Bruker EQUINOX 55 FT-IR spectrophotometer in KBr pel-
lets. The electronic absorption spectra were recorded on Shi-
madzu UV-3600 UV-Vis-NIR spectrophotometer equipped with 
a CPS-240 temperature controller. Diffuse reflectance spectra 
were measured in BaSO4 pellets with BaSO4 as a reference on 
Shimadzu 2101PC equipped with an ISR-260 integrating sphere 
attachment. Complex stability measurements in DMSO/H2O 
(20 µL/3mL) mixture were performed at a pH = 7.00 and at pH = 
2.00 (0.1M KCl, HCl added to adjust the pH). The spectra were 
measured every 340 s at 36.7 oC on Shimadzu UV-3600 UV-
Vis-NIR spectrophotometer in 1 cm UV cuvettes. The magnetic 
susceptibility measurement was performed on a SHERWOOD 
SCIENTIFIC magnetic susceptibility balance. The EPR meas-
urements were performed at room and liquid nitrogen temper-
atures with a Bruker ELEXSYS E-500 spectrometer operating 
at the X band (9.8 GHz) and 100 kHz magnetic field modulation 
equipped with super-high-sensitivity cavity ER 4122 SHQE. 
The EPR parameters of the vanadium complex were determined 
by fitting the spectra using the EPRSim32 simulation package 
[18]. The estimated error of the g factor was ±0.001 whereas in 
the case of HFS parameters the one was ±1 G.
Syntheses 
The syntheses of three vanadium(III,IV,V) complexes were car-
ried out in the one step reaction, ethanol was used as a solvent 
and reactions were proceeding under anaerobic conditions (Ar). 
The Schiff base ligands were synthesized in situ in 1 : 1 molar 
ratio from components (aldehydes and hydrazides) prior of va-
nadium source addition. The structure of ligands H2L1 – H2L3 is 
presented in Scheme 1.
[V(L1)(HL1)]·EtOH, 1
3,5-dibromo-4-methoxy-salicylaldehyde (0.929 g, 3.0 mmol), 
phenylacetic hydrazide (0.450 g, 3.0 mmol) and EtOH (25 ml) 
were refluxed under Ar for 10 minutes. Formation of white pre-
cipitation was observed. Then [V(acac)3] (0.590 g, 1.7 mmol) 
was added and the reflux was continued for 35 minutes. The for-
mation of precipitate (very small amounts) was observed. The 
mixture was evaporated to ½ of initial volume and the product 
was filtered off while hot. Yield 1.148 g. MW = 977.18. Anal. 
Calcd. for C34H31Br4N4O7V: C, 41.79; H, 3.09; N, 5.73 %. Found: 
C, 41.45; H, 2.85; N, 6.03 %. The complex is paramagnetic, µ = 
2.55 µB.
[VO(L2)(phen)]·2H2O, 2
5-chlorosalicylaldehyde (0.234 g, 1.5 mmol), 4-hydroxybenzhy-
drazide (0.224 g, 1.5 mmol) and EtOH (50 ml) were refluxed un-
der Ar for 10 minutes. The light yellow solution was formed and 
then solid [VO(acac)2] (0.399 g, 1.5 mmol) was added and the 
mixture was refluxed for additional 20 minutes. The mixture be-
comes brown and no crystal formation was observed. Then phen 
(0.277 g, 1.5 mmol) in 10 ml of EtOH was added. The solution 
becomes blooded-red and it was left for crystallization, as no 
precipitation was observed at this stage. The next day formation 
of crystals was observed. These were filtered off, washed with 
small amount of cold EtOH and dried in air. Yield 0.514 g. MW 
= 571.86. Anal. Calcd. for C26H21ClN4O6V: C, 54.61; H, 3.70; N, 
9.80 %. Found: C, 54.54; H, 3.57; N, 9.58 %. The complex is 
paramagnetic, µ = 1.52 µB.
[VO(L3)(EtO)], 3
5-chlorosalicylaldehyde (0.53 g, 1.5 mmol) and 2-hydroxyben-
zhydrazide (0.230 g, 1.5 mmol) in 25 ml of EtOH were refluxed 
Scheme 1. Structure of ligands H2L1 – H2L3
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for 15 minutes under Ar. The insoluble Schiff base was formed 
and solution becomes light yellow. Then VOSO4 aq (0.333 g; 
1.5 mmol) was added and reflux was continued for 55 minutes. 
The solution becomes transparent, very dark yellow without any 
precipitation. The reflux was removed and the solvent was evap-
orated but no precipitation was observed. Thus water was added 
and the mixture was sonicated for several minutes. The com-
plex was filtered off, washed with water 3 times and dried in air. 
Yield 0.574 g. MW = 400.69. Anal. Calcd. for C16H14ClN2O5V: C, 
47.96; H, 3.52; N, 6.99 %. Found: C, 48.34; H, 3.49; N, 7.05 %. 
The complex is diamagnetic.
Crystallographic data collection and structure 
refinement 
Diffraction intensity data for single crystal of the compound 
3 were collected at a room temperature on a KappaCCD (No-
nius) diffractometer with graphite-monochromated Mo Kα 
radiation (λ = 0.71073 Å). Cell refinement and data reduction 
were performed using firmware [19, 20]. Positions of all of 
non-hydrogen atoms were determined by direct methods using 
SHELXL-2017/1 [21]. All non-hydrogen atoms were refined 
anisotropically using weighted full-matrix least-squares on 
F2. Refinement and further calculations were carried out using 
SHELXL 2017/1 [21]. All hydrogen atoms joined to carbon at-
oms were positioned with an idealized geometries and refined 
using a riding model with Uiso(H) fixed at 1.5 Ueq of C for methyl 
groups and 1.2 Ueq of C for other groups. The hydrogen atom of 
-OH (O19) substituent was found in the difference-Fourier map 
and refined with an isotropic thermal parameter. The figures 
were made using DIAMOND software [22]. CCDC 1883287 
contains the supplementary crystallographic data for the com-
plex. These data can be obtained free of charge from the Cam-
bridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/
data_request/cif.
Results and Discussion 
The reaction of [V(acac)3], [VO(acac)2] or VOSO4aq, in anaer-
obic conditions, with Schiff base ligand components, listed in 
materials and methods section, leads to formation of tridentate 
ONO ligand and for 1 and 2 release of acac- ions. For V(III) com-
plex (1) two Schiff base ligands are coordinated to octahedral 
vanadium center, one as 2- anion (with deprotonated phenolic 
OH group of salicylaldehyde imine nitrogen and oxygen from 
deprotonated hydrazide) and second as 1- anion (with depro-
tonated phenolic OH group of salicylaldehyde imine nitrogen) 
for this non-oxido vanadium(III) complex. In case of V(IV) (2), 
when as a substrate a [VO(acac)2] was used, for stabilization of 
the IV oxidation state and to fill the coordination sphere to six, 
bidentate 1,10-phenanthroline was used. Thus octahedral coor-
dination sphere of vanadium(IV) is composed of oxido ligand, 
ONO twice deprotonated L2 ligand and two nitrogen donor at-
oms of phen. When a co-ligand was not added, the compounds 
were oxidized in the presence of air, yielding V(V) salts as in 
case of complex 3. All complexes are stable in air, well soluble 
in the organic solvents and slightly soluble in water.
1. Crystal structure 
The complex 3 crystallizes in the triclinic space group P-1 with 
the asymmetric cell unit containing one molecule of [VO(L3)
(EtO)] complex. The crystallographic data and detailed infor-
mation on the structure solution and refinement for 3 are given 
in Table 1 while the molecular structure with the atom labelling 
scheme is illustrated in Fig. 1. The selected bond parameters are 
summarized in Table 2. Vanadium is in distorted square pyram-
idal geometry, with (L3)2- and EtO- in pyramid plane. Ligand 
(L3)2- is planar, only N9 and O12 are shifted off plane by 0.279 Å 
and 0.287 Å respectively. This plane form an angle of 3.30 o with 
that defined by atoms O7, O12, O21 and N9. Vanadium atom is 
shifted toward vanadyl oxygen O20 from this last plane by 0.470 
Å. This a rear example of pure square pyramid geometry. The 
V=O distance (1.577 Å) is typical for double bond, the V-N9 
(2.115 Å) and V-O (1.758 Å) to EtO- oxygen bond distances in-
dicate on strong bonding of ethoxy ligand. The V-O7 bond dis-
tance (1.829 Å) and V-O12 (1.928 Å) indicate stronger torsions 
in pentagonal ring than in hexagonal (with O7) one. The EtO- 
ligand shows two distinct positions in the structure, as shown 
in Fig. 1. There are two isomers present in the crystal structure, 
looking from EtO- ligand 5-atomic ring is on the left or on the 
right sight of the molecule. In unit cell, the 1:1 stoichiometry of 
isomers is observed. 
Table 1. Crystal data and structure refinement for 3
Empirical formula C16 H14ClN2O5V
Formula weight 400.68
Temperature 293(2) K
Wavelength 0.71073 Å
Crystal system Triclinic
Space group P -1
Unit cell dimensions a = 7.5605(6) Å α = 90.196(4)°
b = 8.6791(7) Å β = 99.341(4)°
c = 12.9344(8) Å γ = 98.891(4)°
Volume 827.06(11) Å3
Z 2
Density (calculated) 1.609 Mg/m3
Absorption coefficient 0.791 mm-1
F(000) 408
Crystal size 0.350 x 0.180 x 0.060 mm3
Theta range for data collection 2.376 to 27.612°
Index ranges -9≤h≤9, -11≤k≤11, -5≤l≤16
Reflections collected 3734
Independent reflections 3734 [R(int) = 0.0706]
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Completeness to theta = 25.242° 98.9 % 
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3734 / 4 / 252
Goodness-of-fit on F2 1.035
Final R indices [I>2sigma(I)] R1 = 0.0786, wR2 = 0.1923
R indices (all data) R1 = 0.1157, wR2 = 0.2106
Largest diff. peak and hole 0.666 and -0.647 e.Å-3
Figure 1. The asymmetric part of the unit cell of the complex 3 with adopted 
atomic numbering scheme. All non-hydrogen atoms are represented at 30% 
probability thermal ellipsoids
The molecular packing is shown in Fig. 2. The structure is 
stabilized by a net of hydrogen bonds, shown in Fig. 3 and strong 
π-π interactions shown in Fig. 4. The numerical data are present-
ed in Table 3 and 4. The D-A distances indicate that hydrogen 
bonds are relatively long, the DHA angle rather far from 180o 
indicate that hydrogen bonds are very weak. The structure is 
stabilized also by π-π stacking interactions listed in Table 4 and 
shown in Fig. 4. The stacking interaction are in between aromat-
ic rings of ligand L3. All these interactions form a three-dimen-
sional net that stabilize the structure of 3.
Bond lengths Bond angles
V(1)-O(20)  1.577(4)
V(1)-O(21)  1.758(3)
V(1)-O(7)  1.830(3)
V(1)-O(12)  1.929(4)
V(1)-N(9)  2.115(4)
Cl(1)-C(4)  1.737(5)
O(21)-C(22A)  1.456(14)
O(21)-C(22B)  1.457(18)
O(19)-C(14)  1.356(6)
O(7)-C(1)  1.355(5)
O(12)-C(11)  1.315(5)
N(9)-C(8)  1.284(6)
N(9)-N(10)  1.390(5)
C(1)-C(6)  1.396(6)
C(1)-C(2)  1.402(7)
N(10)-C(11)  1.299(6)
C(5)-C(4)  1.379(7)
O(20)-V(1)-O(21) 107.5(2)
O(20)-V(1)-O(7) 107.56(19)
O(21)-V(1)-O(7) 99.62(15)
O(20)-V(1)-O(12) 103.89(18)
O(21)-V(1)-O(12) 88.94(16)
O(7)-V(1)-O(12) 142.95(16)
O(20)-V(1)-N(9) 96.87(17)
O(21)-V(1)-N(9) 153.19(18)
O(7)-V(1)-N(9) 82.92(14)
O(12)-V(1)-N(9) 74.29(14)
C(22A)-O(21)-V(1) 130.1(9)
C(22B)-O(21)-V(1) 139.4(8)
C(1)-O(7)-V(1) 135.0(3)
C(11)-O(12)-V(1) 118.6(3)
C(8)-N(9)-N(10) 116.2(4)
C(8)-N(9)-V(1) 128.7(3)
N(10)-N(9)-V(1) 115.1(3)
Table 2. Selected bond lengths [Å] and angles [°] in 3
Figure 2. The crystal packing in 3 through [100] direction. Hydrogen atoms 
omitted for clarity
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Table 3. Hydrogen bonds [Å] and angles [°] in 3
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
C(8)-H(8)...O(20)#1 0.93 2.59 3.355(6) 139.7
C(2)-H(2)...O(19)#2 0.93 2.50 3.394(6) 161.3
O(19)-H(19O)...N(10) 0.95(2) 1.76(5) 2.614(5) 148(7)
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,-y+1,-z #2 x-1,y-1,z 
Table 4. The π⋅⋅⋅π interactions in 3 [Å]
Cg1····Cg2 [1-X,1-Y,-Z] 3.9518(3) 
Cg2····Cg1 [1-X,1-Y,-Z] 3.9518(3) 
Cg1: C(1)-C(2)-C(3)-C(4)-C(5)-C(6)
Cg2: C(13)-C(14)-C(15)-C(16)-C(17)-C(18)
2. IR spectra 
The infrared spectra for 1-3 were recorded in a 400 – 4000 cm-1 
range and are presented in Fig. 5. In the region characteristic 
for V=O vibration (900 – 1000 cm-1) there are bands at 957 cm-1 
for 2 and at 965 cm-1 for 3. For complex 1 the νV=O band does 
not appear which confirms its non-oxido character. For all com-
plexes the band at 1576 cm-1 (for 1), 1607 cm-1 (for 2) and 1622 
cm-1 (for 3) is assigned to the vibration of C=N group in Schiff 
base ligand. Lower position of this band for 1 may be related 
to the participation of two nitrogen atoms of imine groups in 
coordination to the vanadium(III) center. For complex 2 there 
are also well seen the intensive bands at 724, 1425 and 1493 cm-1 
connected with the vibration in the 1,10-phenanthroline ligand. 
These bands were also observed in the other d-electron metal 
Figure 3. Hydrogen bonds in 3. H-atoms (without H2, H8 and H19) are omitted for clarity
Figure 4. The π-π interactions in 3. Hydrogen atoms are omitted for clarity
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complexes with 1,10-phenanthroline ligand [23]. For this com-
plex the wide band at 3407 cm-1 may be associated with the pres-
ence of water of hydration which also stay in agreement with the 
complex formula. For complexes 1 and 3 there are low intensity 
bands in a 2800 – 3100 cm-1 range and are related to νOH vibration 
of EtOH in 1 and EtO- ligand in 3. The other parts of the spectra 
are dominated by bands derived from the organic ligand.
2. UV-Vis spectra 
The UV-VIS spectra in 200-800 nm range are presented in Figs. 
6-8 for complexes 1-3, respectively. For complexes 1 and 2 spec-
tra are shown in EtOH and MeCN, while for 3 in several oth-
er solvents to indicate the solvatochromism of the CT (charge 
transfer) band at ca. 400 nm which is attributed to MLCT 
(metal-to-ligand charge-transfer) transition (connected with the 
coordinated Schiff base ligand). In UV part CT bands of the 
ligands L1 – L3 can be observed. The doubling of the bands in 
the UV part (in 1) can be a result of two different forms of proto-
nated ligand, (HL1)- and (L1)2-, present in the complex unit. The 
reflectance spectra of 1 and 3 are presented in Fig. 9. The lack of 
the bands in the d-d region (above 700 nm) underlines the V(III) 
and V(V) oxidation states in 1 and 3 respectively. 
The most important was to study the stability of the complex-
es in solutions as well as dependence of this stability at different 
pH. As for biological studies the solutions of complexes have to 
be prepared, which then were injected to cell cultures, the sta-
bility of solutions was crucial. Also the solubility in water was 
very important. We have found, that all complexes are almost 
insoluble in water, thus we had to prepare water-organic solvent 
mixtures. The highest solubility of all complexes was found in 
DMSO as solvent, thus for this solvent water-DMSO mixtures 
of lowest organic solvent content could be prepared. We have 
also found, that solutions in DMSO are very stable in time and 
mixtures of 20 µl of DMSO complex solution with 3 ml of water 
could be prepared without complex precipitation. We have stud-
ied the stability of such mixtures versus time at pH neutral (7.0) 
and at pH 2.0, this last as representing the medium pH found in 
human stomach. The results of this investigations are presented 
in Figs. 10-12. In general most stable are the solutions at pH = 
7.0, while at pH = 2 we observed the strong diminishing of the 
band in 400 nm region indicating complex decomposition with 
releasing the ONO ligands L. 
Figure 5. The IR spectra for 1 (black line), 2 (red line) and 3 (blue line)
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Figure 6. The electron spectra of 1 in ethanol and acetonitrile, d = 1 cm
Figure 7. The electron spectra of 2 in ethanol and acetonitrile, d = 1 cm
Figure 8. The qualitative electron spectra of 3 in different organic solvents, d = 1 cm
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Figure 9. The reflection spectrum of 1 (black line) and 3 (red line) after Kubelka-Munk transformation
Figure 10. The electron spectra of 1 in DMSO-H2O mixture (20µl + 3 ml) at pH = 7.00 (left) and 2.00 (right). T = 37oC, d = 1 cm, c = mol/dm3,  
15 spectra measured every 340s. The arrows indicate the direction of the changes
Figure 11. The electron spectra of 2 in DMSO-H2O mixture (20µl + 3 ml) at pH = 7.00 (left) and 2.00 (right). T = 37oC, d = 1 cm, c = mol/dm3,  
15 spectra measured every 340s. The arrows indicate the direction of the changes
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3. EPR spectrum 
The EPR spectrum of complex 1 is presented in Fig. 13. Due 
to measured magnetic moment of 2.55 µB (calculated for V(I-
II) 2.83 µB, for V(IV) 1.73 µB), it must be stressed, that 1 con-
tains V(III), not visible in the EPR X-band, and only very small 
amounts of V(IV). The presence of this signal (Fig. 13) can be at-
tributed to the small quantities of V(IV) formed by oxidation of 
complex 1. The spectrum is a superposition of two signals which 
were simulated with the following parameters: center C1’ g|| = 
1.946, A||= 179.3 G, g⊥ = 1.980, A⊥ = 63.6 G and C2’ g|| = 1.921, 
A||= 180.9 G, g⊥ = 1.979, A⊥ = 69.8 G. The 51V hyperfine coupling 
constant (179 for 1) indicates, that V(IV) presents in 1 exists in 
V=O form, for the nonoxo V(IV) complexes the hyperfine cou-
pling usually are lower than 130 G. [24]. This indicates, that ox-
idation of 1 results in ring opening and formation of oxido form. 
Conclusions
Three new complexes of V(III), V(IV) and V(V) with tridentate 
ONO Schiff base ligands were synthesized and characterized. 
The X-ray single crystal structure of complex 3 indicates rare 
pure square pyramidal geometry of vanadium central atom. 
The EPR measurements show, that V(III) is contaminated with 
a small amount of V(IV) oxido complex, while most of the com-
plex is of nonoxido type. The stability of the solutions indicate, 
that they can be used for cell culture media investigations, but 
in in vivo studies injections are recommended as complexes are 
relatively unstable at pH typical for digestion system. 
Figure 13. X-band EPR spectrum of complex 1 registered at RT. Black line: simulated 
spectra, red line: experimental spectra 
Figure 12. The electron spectra of 3 in DMSO-H2O mixture (20µl + 3 ml) at pH = 7.00 (left) and 2.00 (right). T = 37oC, d = 1 cm, c = mol/dm3,  
15 spectra measured every 340s. The arrows indicate the direction of the changes
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